Quick Answer
Co-Diagnostics, Inc. reported Operating Income of -$50.17 million for fiscal year 2025.
Co-Diagnostics, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$50.17M | -25.2% |
| 2024 | -$40.08M | +6.1% |
| 2023 | -$42.71M | -58.3% |
| 2022 | -$26.98M | -158.6% |
| 2021 | $46.06M | +10.5% |
| 2020 | $41.69M | +807.4% |
| 2019 | -$5.89M | +3.7% |
| 2018 | -$6.12M | -34.0% |
| 2017 | -$4.56M | -170.4% |
| 2016 | -$1.69M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$7.01M | +31.5% | +13.0% |
| June 30, 2025 | -$8.06M | -4.9% | +5.8% |
| March 31, 2025 | -$8.55M | +16.6% | +16.4% |
| September 30, 2024 | -$10.23M | -14.5% | -33.3% |
| June 30, 2024 | -$7.68M | +36.0% | +25.1% |
| March 31, 2024 | -$10.26M | -3.1% | -14.8% |
| September 30, 2023 | -$8.94M | -36.7% | +25.5% |
| June 30, 2023 | -$11.99M | -189.2% | -20.5% |
- Co-Diagnostics, Inc. showed a decrease of -25.2% in Operating Income compared to the prior fiscal year.
- Over the 2016–2025 period, Co-Diagnostics, Inc.’s operating income has declined by 2871.9% (from -$1.69 million to -$50.17 million).
- The most recent figure is from Co-Diagnostics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: